World News | Agence France-Presse | Wednesday October 14, 2020
US pharmaceutical firm Eli Lilly on Tuesday paused a late-stage trial of its experimental lab-produced antibody treatment against Covid-19 over an unspecified safety concern, the company said.
www.ndtv.com